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Abstract
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Heme oxygenase, HO, cleaves hemin into biliverdin, iron and CO. For mammalian HOs, both
native hemin propionates are required for substrate binding and activity. The HO from the
pathogenic bacterium Neisseria meningitidis, NmHO, possesses a crystallographically undetected
C-terminal fragment that by solution 1H NMR is found to fold and interact with the active site.
One of the substrate propionates has been proposed to form a salt bridge to the C-terminus rather
than to the conventional buried cationic side chain in other HOs. Moreover, the C-terminal
dipeptide Arg208His209 cleaves spontaneously over ~24 hours at a rate dependent on substituent
size. 2D 1H NMR of NmHO azide complexes with hemins with selectively deleted or rearranged
propionates all bind to NmHO with a structurally conserved active site as reflected in optical
spectra and NMR NOESY cross peak and hyperfine shift patterns. In contrast to mammalian HOs,
NmHO requires only a single propionate interacting with the buried terminus of Lys16 to exhibit
full activity and tolerates the existence of a propionate at the exposed 8-position. The structure of
the C-terminus is qualitatively retained upon deletion of the 7-propionate but a dramatic change in
the 7-propionate carboxylate 13C chemical shift upon C-terminal cleavage confirms its role in the
interaction with the C-terminus. The stronger hydrophobic contacts between pyrroles A and B
with NmHO contribute more substantially to the substrate binding free energy than in mammalian
HOs, “liberating” one propionate to stabilize the C-terminus. The functional implications of the Cterminus in product release are discussed.
Heme oxygenase, HO1, is the widely distributed enzyme (1) that utilizes hemin as both
substrate and cofactor to stereospecifically cleave a single meso position to generate
biliverdin, iron and CO, proceeding via the intermediates depicted in Scheme 1.
†This research was supported by grants from the National Institutes of Health, GM62830 (GNL), and CA132861 (KMS); NMR
instrumentation purchase was supported by grants from the National Institutes of Health, RR1973, and the National Science
Foundation, DBIO722538.
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In mammals, the three products serve as a precursor to the powerful antioxidant bilirubin, as
a source of 97% of the required iron and as a neural messenger, respectively (2-6). In plants
and photosynthetic bacteria, the product open tetrapyrrole serves as a precursor to lightharvesting pigments (7), while the released iron is vital to infection for some pathogenic
bacteria; (2, 4). The mammalian HOs have been the most extensively studied (3) and, in
spite of only limited sequence homology (4), both the characteristic α-helical topology
(8-13) and the mechanism (2, 4, 6) are conserved among other HOs. The relatively loose
binding of substrate by HOs, as evidenced by both numerous vacancies and variable position
of structural elements (8-13), involves an axial bond to a His, two salt-bridges between the
ubiquitous propionates and two suitably positioned cationic side chains as depicted in Figure
1A; the remaining interactions are relatively weak van der Waal contacts with pyrroles A
and B.

$watermark-text

The stereoselectivity of the cleavage arises from the steric effect of the distal helix which
tilts the active Fe3+-OOH toward one meso position while blocking the remaining three
meso positions (9-13). The particular meso position cleaved depends on the in-plane
orientation of the substrate relative to the distal helix. Only the α-meso position is cleaved in
mammalian HOs. The crucial role of propionate links in determining the in-plane
orientation, and hence stereoselectivity, of substrate cleavage is confirmed by studies on
human HO, hHO, (14) mutants where repositioning the cationic side-chains leads to a ~90°
in-plane rotation of substrate with concomitant conversion of α-meso to mixed β, δ-meso
cleavage. Earlier studies of human HO, hHO, with a variety of modified substrates (15, 16),
have revealed that, while there is toleration for a wide range of substituents on pyrroles A
and B (Figure 1B), the two propionates at positions 6 and 7 must both be conserved to retain
activity.
In spite of sharing the same folding topology and mechanism with mammalian HOs, the
HOs from pathogenic bacteria (2, 4-6) exhibit some distinct properties relative to function.
Three pathogenic bacterial HOs have been structurally characterized, those from Neisseria
meningitidis (9, 11), NmHO, Pseudomonas aeruginosa (13), PaHO, and Corynbacterium
diphtheria (12), CdHO. CdHO, which exhibits the closest sequence and structural homology
(4, 6, 12) to mammalian HOs, exhibits the same stereoselectivity, sensitivity to mutation
(17), and similar 90° in-plane rotation, and altered stereoselectivity, upon mutation of
cationic residues(18), as mammalian HOs (14, 19). PaHO exhibits (13, 20) mixed β-,δ-meso
cleavage due to an ~90° in-plane rotation of protohemin-IX relative to that in mammalian
HOs, resulting from the rearrangement of cationic side chains in the wild-type protein.
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NmHO exhibits numerous distinct properties. While there is normal α-meso cleavage
consistent with protohemin-IX oriented as depicted in Figure 1B, the structure of the active
site is more compact and has fewer vacancies(9, 11) than in other HOs. The roles of the
propionates in the crystal structures are not well-defined and key C-terminal residues are
undetected (9, 11). In contrast, solution NMR has demonstrated that the C-terminal
fragment, His207Arg208His209, is, in fact, ordered and interacts with the active site
(21-24). A molecular model based on limited energy minimization and using as constraints
limited NOESY data and a series of proposed salt bridges suggested by the crystal structure,
has been offered (22, 24) and is reproduced in Figure 2. We note that this model utilizes one
of the two propionates (at native PHIX position 7 in the crystal (9, 11)), leaving but one
propionate to make the conventional salt bridge to the protein matrix. Surprisingly, the
NmHO C-terminus cleaves spontaneously upon substrate binding (22) to yield a complex
with an increased rate of product release. The fact that the necessary acceleration of product
release (25) in mammalian HOs occurs (3) by the binding of biliverdin reductase, BVR, at
the exposed substrate site(26) that is homologous to the site of the C-terminal interaction in
NmHO, demands a more quantitative understanding of the C-terminus in the latter complex.
Biochemistry. Author manuscript; available in PMC 2012 December 05.
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We have pursued detailed 1H NMR studies (21-24, 27)of systematically perturbed
interactions of the substrate with NmHO in general, and its C-terminal fragment in
particular, to evaluate the molecular model (Figure 2) and ascertain the structural features
that favor the facile cleavage of the C-terminus. Studies of the three sequential C-terminal
deletion mutants directly confirmed (24) the substrate contacts to His207 and Arg208 and
indicated the existence of a salt bridge for the C-terminal carboxylate with a cationic side
chain of both Arg208 and Lys126. Systematic variation of substrate pyrroles A/B
substituents revealed (27) a much tighter interaction between substrate and protein matrix,
and hence much stronger descrimination between the alternate substrate orientation about
the α,γ-meso axis, than in any other HO (20, 28-30), and that the C-terminal cleavage rate
increased (24) as the pyrrole A substituent size decreased. Herein we complete these studies
by perturbing the substrate propionates, both by replacement of individual propionates by
methyls, as well as by interchanging methyl and propionate on one pyrrole, in order to
ascertain whether the propionates must be conserved for activity, as found in mammalian
HOs (15, 16), and identify the interactions of the propionates at each position.
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To this end, we take advantage of a series of modified hemins (31, 32) depicted in Figure 3
designed to illuminate the interaction of substrates with NmHO relative to that in
mammalian HOs; labeling of these substrates is based on modifications of protohemin-IX
(PHIX) and 2-4-dimethyldeuterohemin-IX (DMDHIX). We emphasize the low-spin azide
complex where the novel orbital ground state (33) results in strongly contact-shifted, and
hence resolved, signals (24, 27, 34, 35) for the protons on the substrate edge exposed to
solvent which makes contact to the C-terminus (see Figure 2). While relaxation for the azide
complexes is somewhat stronger for the more frequently studied cyanide complexes (36), it
does not seriously interfere with effective 2D NMR analysis (24, 27, 35), and the
physiological oxy-complex is more reasonably modeled by the bent azide than the linear
cyanide ligand.

MATERIAL AND METHODS
Materials

$watermark-text

The wild type, WT, Neisseria meningitidis heme oxygenase, NmHO, was prepared and
purified as described in detail previously (21). The two derivatives of protohemin-IX with
selective methyl for propionate substitutions, 6-de-propionate-,6-methyl-protohemin-IX, and
7-de-propionate-,7-methyl-protohemin-IX, labeled (6P→M)PHIX and (7P→M)PHIX, 2-,4dimethyldeuteroheme-IX, DMDHIX, and protohemin-XIII, PHXIII, (which possesses the
symmetric 1-,4-divinyl arrangement) are the same as described in detail previously (32). The
two hemins with selective removal or rearrangement of propionates, based on 2-,4dimethyldeuterohemin-IX (labeled DMDHIX, are 7-de-propionate-,7-methyl-2-,4dimethyldeuterohemin-IX, labeled (7P→M)DMDHIX, and 7-de-propionate-,7-methyl-,8de-methy,8-propionate-2-,4-dimethyldeuterohemin-IX, labeled (7P→M:-8M→P)DMDHIX,
which were prepared as described elsewhere (31). The positions on the DMDHIX and
PHXIII derivatives are labeled (see Figure 3) on the basis of the orientation of native
protohemin-IX in the crystal structure, as shown in Figure 1B (9, 11). The carboxylates of
native protohemin-IX were 95% 13C-labeled singly or doubly to yield 6-(13CγO −2)PHIX
and 6,7-(13CγO −2)2PHIX, respectively, as described elsewhere (37).
The 1:1 complexes of the substrate of interest with NmHO were prepared as described
previously (21) for the PHIX and DMDHIX complexes, except that the mono-propionate
hemins were dissolved in 95% H2O, 5% pyridine, with the pyridine removed immediately
after preparation via Sephadex column chromatography, as described previously for the
reaction with globins (38). The quantitative incorporation of each substrate into NmHO was
confirmed both by the characteristic uv-visible spectra as the cyanide complexes and the
Biochemistry. Author manuscript; available in PMC 2012 December 05.
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identification of the signals in the 1H NMR spectrum as the azide complexes. Samples
for 1H NMR were concentrated by ultrafiltration to yield ~2mM samples in 50 mM
phosphate, 75 mM azide, pH ~7.1.
UV-visible spectroscopy
Spectra were recorded on a Varian Cary 50 uv-visible spectrometer over the range
200-800nm at a rate of 50 nm/s; 32 transients were averaged. The sample NmHO substrate
complexes were 30 mM in cyanide 50 mM in phosphate, pH 7.1.
In vitro enzyme assay

$watermark-text

The activity of the various substrate complexes of NmHO was determined by following by
uv-visible spectroscopy the effect of reaction with ascorbate, in the presence of the iron
chelator desferrioxamine, in the conversion of hemin to biliverdin, as described in detail
previously (21). Subsequently, the product biliverdin was reacted with rat biliverdin
reductase, prepared as described elsewhere (39), and NADPH to generate bilirubin.
NMR spectroscopy
1H

$watermark-text

NMR data were collected on Bruker AVANCE 500 and 600 spectrometers operating at
500 and 600 MHz, respectively. 1H chemical shifts are referenced to 2,2-dimethyl-2silapentane-5-sulfonate (DSS) through the water resonance calibrated at each temperature.
Reference spectra were collected over a 65 ppm spectral width and a repetition rate 2.5 s−1.
600 MHz NOESY spectra (40) (mixing time 40 ms; repetition rate 1.5 to 2.5 s−1) and 500
MHz Clean-TOCSY spectra (41) (to suppress ROESY response; 25°, 35°C, spin lock 25 ms;
repetition rate 1-2 s−1) were recorded over a bandwidth of 20 and 45 ppm (NOESY) and 20
ppm (TOCSY) using 512 t1 blocks of 128 and 256 scans each consisting of 2048 t2 points.
2D data sets were apodized by 30°- or 45°-sine-squared-bell-functions and zero-filled to
2048 × 2048 data points prior to Fourier transformation.
1H-decoupled 13C

NMR spectra were recorded at 125 MHz on a Bruker AVANCE 500
spectrometer over a bandwidth 300 ppm at the repetition rate of 1 s−1 at 25° C utilizing 32K
data points. The 13C chemical shifts were indirectly referenced to the proton spectrum (42).

RESULTS
Structural integrity of propionate-modified substrate complexes

$watermark-text

The reaction of (6P→M)PHIX and (7P→M)PHIX with NmHO, in the presence of excess
cyanide resulted in the same characteristic changes in their uv-visible spectra as observed for
native PHIX, while reaction of (7P→M)DMDHIX and (7P→M:8M→P)DMDHIX with
NmHO in the presence of excess cyanide resulted in the same uv-visible spectral changes as
observed for the DMDHIX complex (Supporting Information Figure S1). The near identity
of the uv-visible spectra of the NmHO complexes with the propionate modified and
“normal” dipropionate substrates support the incorporation of the modified substrate into an
environment that is essentially the same as that for PHIX and DMDHIX. The 1H NMR
spectra of the azide complexes of (7P→M)PHIX and (6P→M)PHIX are presented in
Figures 4B and 4C, respectively, where they can be compared with that of the complex with
native PHIX (Figure 4A). Also included is the 1H NMR spectrum of the azide complex for
the two-fold symmetric PHXIII (Figure 4D). The NMR spectra of the NmHO azide
complexes of (7P→M)DMDHIX and (7P→M:8M→P)DMDHIX are shown in Figures 5B
and 5C, respectively, and can be compared with that of the previously characterized
DMDHIX complex (24) shown in Figure 5A. The NMR spectra in Figures 4B, 4C, 4D, 5B
and 5C display a strongly dominant single set of hyperfine shifted methyl signals which

Biochemistry. Author manuscript; available in PMC 2012 December 05.
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indicate an unique orientation of the modified substrates within an active site very similar to
that observed for the “normal” dipropionate PHIX and DMDHIX.
Activity of modified substrate complexes

$watermark-text

The complexes with modified substrates all underwent reaction with ascorbate in the
presence of the iron chelator, desferrioxamine, in a standard assay (22) that yielded uvvisible spectra with characteristic broad bands at ~380 and ~670 nm (43) indicative of
biliverdin formation, with the resulting spectra largely indistinguishable from those of the
related substrates with the two normal propionates (Supporting Information Figure S2).
Subsequent reaction of the biliverdin with rat biliverdin reductase (39) and NADPH
afforded the spectra indicative of bilirubin formation. Thus, HO activity is conserved upon
either deletion of one propionate or exchange between a propionate and methyl on the same
pyrrole.
Substrate/active site residue assignment protocols

$watermark-text

Substrate protons for the major isomers in solution are labeled Mi(Hi) for methyl (single
proton) at pyrrole positions i=1-8 (see Figure 1). Residue protons are labeled by residue
number and position; peptide protons are labeled only by position. Unambiguous assignment
of the substrate resonances is obtained by characteristic NOESY connectivities about the
periphery and is facilitated by the expected pattern of substrate hyperfine shifts (24, 27, 35).
On the one hand, cross peaks between a pair of methyls on the same pyrrole (adjacent to a
common meso position) are strong (weak). Methyl to vinyl Hβs (Hαs) NOESY cross peaks
are strong for a vinyl oriented cis (trans) to its adjacent methyl (27) as depicted in Figure 3.
On the other hand, the known orbital ground state for the azide complex places large τ spindensity (24, 27, 34, 35)only at positions 1, 4, 5 and 8, such that methyl and vinyl Hαs appear
strongly shifted to low field, with the vinyl Hβs exhibit strongly upfield shifted and resolved
resonances. Substrate chemical shifts for pyrrole α-substituents are listed in Table 1;
complete substrate assignments and active site residue assignments are provided in
Supporting Information, Tables S1, S2 and S3, S4.
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Active site residues are assigned sequence-specifically (44) by characteristic backbone
NOESY cross peaks among TOCSY-detected residues characteristic of an α-helix (data not
shown) as described in detail previously for a series of NmHO and hHO azide complexes
(24, 27, 35). These studies afford the assignments for the helical fragments; proximal helix
Thr19-Val26, Phe52-Lys54, distal helix Tyr112-Gly116, Phe123-Phe125, Arg140-Leu142
and Ala180-Tyr184. The two residues focal to establishing the orientation of a substrate in
the active site (27) are Phe123 in contact with substituents at positions 1 and 8, and Cys113
in contact with substituents at positions 4 and 5 in the crystal structure (Figure 1B).
Chemical shifts for the axial His23 are included in Table 1 and for other residues are
provided Supporting Information, Tables S3 and S4.
Seating of propionate-modified substrates
To uniquely place modified substrates in the active site of NmHO we will describe the
proton at a given position on the modified substrate, as labeled in Figure 3, and identify
where each of those protons on the substrate is placed in the active site defined by the
position of the PH proton in the crystal structure, as shown in Figure 1B (9, 11). Portions of
the 1H NMR NOESY spectrum of NmHO-(7P→M)PHIX-N3 for assigning the substrate and
active site residues relevant to substrate seating are shown in Figure 6. A weak cross peak
between two low-field methyls (Figure 6B) locates the M1/M8 pair, and an intense cross
peak of one of these to a more weakly low-field shifted methyl (Figure 6H) identifies the
M8/M7 pair. Intense cross peaks of high-field resolved vinyl Hβs to a partially resolved
methyl and a strongly low-field shifted Hα locate the 4-vinyl group and M3 (not shown).
Biochemistry. Author manuscript; available in PMC 2012 December 05.
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The remaining low-field methyl exhibits cross peaks to a moderately low-field shifted pair
of H αs and Hβs that identify the 5-methyl and 6-propionate. The M1 cross peaks to another
vinyl H βs locate the 2-vinyl group and establish that both vinyl groups are oriented cis, as
in the crystal structure (9, 11)for the PHIX complexes, as shown in Figure 3B. The M1 and
M8 cross peaks to Phe123 and the M5 (and 4-vinyl; not shown) cross peak to Cys113 CαH
(Figure 6A) establish an orientation where the lone propionate is in the position of the 6propionate in the crystal structure (Figure 1B). M1/M8 contacts to two residues not predicted
by the crystal structure are observed to both the ring CδH (Figure 6I) and CβH2 (Figure 6A)
of a His and the CαH (Figure 6B) of another residue, in a fashion very similar to that
observed in PHIX and DMDHIX complexes (24, 35). The molecular model and C-terminal
deletions have shown (24) that these contacts involve His207 and the CαH of Arg208.

$watermark-text

The reference spectrum for NmHO-(6P→M)PHIX-N3 exhibits somewhat broader peaks
than the other complexes but still allows the necessary assignments (Supporting Information
Figure S3). The weak, resolved intermethyl cross peak that identifies M1/M8 and their cross
peaks to the Cys113 CαH demonstrate that the orientation of the substrate is rotated 180°
about the α,γ-meso position relative to native PHIX in the crystal (as shown in Figure 3B).
Strongly upfield shifted vinyl Hβs exhibit weak cross peaks to the remaining low-field
methyl and to the vinyl Hα, which in turn, exhibits a cross peak to a partially resolved
methyl, identifying M5, M3 and the 4-vinyl in the trans orientation (as shown in Figure 3C).
A cross peak from M1 to a vinyl H α shows that the 2-vinyl is similarly in the trans
orientation (as depicted in Figure 3B). M5 in the 180°-rotated orientation exhibits cross
peaks to a His CβH2 and the CαH of another residue that dictates their origin as His207 and
Arg208.
The NOESY spectrum of NmHO-(7P→M)DMDHIX-N3 (Supporting Information Figure
S4) locates three pairs of strongly coupled methyls with weak coupling between the pairs,
and another weak coupling to a seventh methyl that uniquely identify M1-M5 and M7, M8.
The M5 contacts to CβHs locates the 6-propionate. The M1/M8 cross peaks to Phe123 and
the M5/M4 cross peaks to Cys113 uniquely determine the orientation where the lone
propionate occupies the same position as does the 6-propionate in the crystal structure
(Figure 3E). The M8/M1 exhibit NOESY cross peaks to both the CβHs and CδH of a His and
the CαH of another residue that identify His207 and Arg208. It is noted that M8 contacts
occur to both the backbone and ring of His207; this latter contact was much weaker or
undetected in the complexes with the native PHIX (or DMDHIX) possessing the normal
propionates at both positions 6 and 7.
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The NOESY spectrum of NmHO-(7P→M:8M→P)DMDHIX-N3 depicts two pairs of
strongly coupled methyls which collectively identify the pairs M1/M2 and M3/M4. A weak
cross peak between the pairs, as well as a weak NOE from one of the pairs to a low-field
methyl, identifies M1-M5; the M5 contacts to a CαH locate the 6-propionate (Supporting
Information Figure S5). A less-strongly low-field shifted methyl exhibits cross peaks to a
low-field shifted C αH and CβHs of a propionate identifying the remaining M7 and 8propionate; H8α exhibits a weak cross peak to M1. Contacts of M1/M8 with Phe123 and M4/
M5 with Cys113 establish the orientation with one propionate occupying the
crystallographic 6-propionate position and the other in the crystallographic 8-positions (as
depicted in Figure 3F). The contact of H8α to a CαH of one residue, and M1/H8α contacts to
the CβHs of an apparent His, represent the interaction of His207 and Arg208 with the active
site. It was not possible to locate the His207 CδH, but M1 and H8α cross peaks to CβHs not
predicted by the crystal structure indicate their origin as His207.
The NOESY spectrum of NmHO-PHXIII-N3 (not shown) identifies all the substrate signals
with the NOESY cross peak of the 1-vinyl H1β to M8 and Phe123 and H1α cross peak to M2,
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indicating that the vinyl group is in a trans position (as depicted in Figure 3C). The 4-vinyl
group exhibits the same cross peaks as in PHIX and hence retains the conventional cis
orientation. The M8/H1β cross peaks to a CβH2 group and the M8 cross peak to a CαH locate
His207 and Arg208. All chemical shift data are provided in Supporting Information, Tables
S1 and S3.
Loss of substrate-residue contacts upon NmHO “aging”

$watermark-text

Over a period of a few days at 25°C, the resolved resonances of the WT NmHO complexes
with (7P→M)PHIX, (7P→M)DMDHIX and (7P→M:8M→P)DMDHIX disappear and are
replaced in the conversion to an “aged”, or homogeneously degraded, derivative which we
label NmHOX. The reference spectra for the three “aged” derivatives are illustrated in
Figure 4B’ and Figures 5B’ and 5C’, respectively. Concomitant to the generation of
NmHOX are observed the appearance of two very narrow resonances in the aromatic
spectral window. Similar conversion of NmHO to NmHOX has been characterized in detail
for both PHIX and DMDHIX complexes and the product shown (21, 22) to be the result of
cleavage of the Arg208His209 dipeptide. In contrast, the WT NmHO complexes of
(5P→M)PHIX and PHXIII exhibit only minor (<10%) “aging” over the same period of
time, dictating that the terminal cleavage rate must be significantly (factor >10) slower
relative to that for either the other propionate modified or native PHIX and DMDHIX
substrates. Unfortunately, the very sparingly available complexes of the propionate-modified
substrates were heterogeneously decomposed upon completion of 2D NMR, precluding
meaningful mass spectrometric studies to characterize the initially cleaved peptide.

$watermark-text

The NOESY spectrum of NmHOX-(7P→M)PHIX-N3 provides the same assignment as for
the WT NmHO complex (not shown). The most prominent difference is that the M1/M8
contacts to the His207 and Arg208 are lost (see Figure 6A’). Similar NOESY data for the
NmHOX complexes of (7P→M)DMDHIX and (7P→M:8M→P)DMDHIX (Supporting
Information Figures S6 and S7, respectively), in each case, exhibit a largely conserved
active site structure but with the loss of the M1/M8 and M1/H1α contacts to His207 and
Arg208. The loss of these contacts is consistent with cleavage of the C-terminus. The
substrate chemical shifts are perturbed upon “aging” in a manner close to that observed (21,
23) for PHIX and DMDHIX. Active site residues chemical shifts are only inconsequentially
perturbed by “aging”. Both substrate (Tables S1, S2) and active site residue (Tables S3, S4)
chemical shifts for the NmHOX complexes are provided in Supporting Information.

$watermark-text

Effect of C-terminal cleavage on the substrate propionate carboxylates
The conversion of native NmHO–PHIX-H O to yield NmHOX 2 -PHIX-H2O by the loss of
Arg208His209 is relatively rapid (half life 24 h) and is readily followed (22) by 1H NMR
via the relative intensities of the resolved M8 peaks. Figure 7A provides the 13C NMR
spectrum in the carboxylate spectral window for NmHO-(6,7-13CO −2)2PHIX-H2O (~90%
NmHO and ~10% NmHOX), which reveals two well-spaced signals, labeled a and b,
uniquely attributable to the two labeled carboxylates. The spectrum of this complex upon
~25% degradation to NmHOX is shown in Figure 7B and identifies the degraded species
with peaks labeled c and d; clearly the chemical shift for one propionate is conserved upon
C-terminal cleavage while the other one significantly perturbed. The 13C NMR spectrum of
a partially degraded, singly labeled complex, NmHO-(6-13CO −2)PHIX-H2O (~75% NmHO,
~25% NmHOX), is shown in Figure 7C and confirms that the propionate sensitive to Cterminal cleavage is clearly that at the crystallographic 7 position.

Biochemistry. Author manuscript; available in PMC 2012 December 05.
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DISCUSSION
Structure of the active site

$watermark-text

Both uv-visible and 1H NMR spectroscopy clearly show that each of the propionatemodified substrates quantitatively incorporate into the active site of NmHO; standard in
vitro assays (22) show that the complexes retain full activity. The 1H NMR data establish
that the substrates seat overwhelmingly in a single orientation that in each case dictates that
the only propionate protein salt-bridge crucial to substrate binding to NmHO is that between
Lys16 with the 6-propionate position in the crystal structure (9, 11). The strong conservation
of active site structure, in spite of the drastic propionate deletion/rearrangement, is
confirmed by not only the conserved pattern of NOESY cross peaks, but also by the
conservation of the pattern of hyperfine shifts. On the one hand, non-ligated active site
residues exhibit only dipolar shifts (36, 45) which sensitively reflect the anisotropy/
orientation of the paramagnetic susceptibility tensor, χ, and the position of the residue. Even
small changes in the orientation of χ can result in large changes in the dipolar shift pattern
(23, 46). The dipolar shifts for crystallographically detected active site residues are highly
conserved among the variable substrates and upon C-terminal cleavage (Supporting
Information Tables S3 and S4) dictating that both the orientation of χ and the residue
geometries are conserved among the complexes.
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On the other hand, ligated His23 and substrate hyperfine shifts are dominated by the contact
interaction (36, 45) (and to a lesser degree, by 2,4-substituents) (47). The data in Table 1
show that the pattern of the His23 CβHs, and hence the orientation of the His imidazole
relative to the protein matrix, is conserved for the various substituents. Substrate methyls
very sensitively reflects the in-plane rotational orientation of the substrate relative to the
axial histidine imidazole plane(36, 48), and by inference, the protein matrix. Thus the
pattern of the M1, M3, M5 and M8 shifts is inconsequentially differentiated within the pair of
complexes of PHIX and (7P→M)PHIX-N3 (see Table 1); the same highly conserved pattern
of M1, M2, M3, M4 and M5 shift pattern is observed within the three complexes of
DMDHIX , (7P→M)DMDHIX-N3 and (7P→M:8M→P)DMDHIX. For the (6P→M)PHIX
complex with the “reversed” orientation (Figure 3B), the pattern of methyl shifts is
conserved relative to that for the equilibrium ~20% populated “reversed” orientation (27) of
native PHIX (data in column 2 of Table 1). This dictates that the in-plane orientation of the
substrate is inconsequentially affected by either deletion or rearrangement of one of the
propionates. Lastly, the low-field bias for H-bond signals for Gln49 and His53, which are
linked to the axial ligand via the catalytic water molecules (9, 11), is strictly conserved.
Structure of the C-terminus and its cleavage
Each of the NmHO complexes of these propionate-modified substrates exhibit contacts to
residues at the crystallographically exposed 1 and 8 positions, (i.e., the positions of the
PHIX 1CH3 and CH3 in the crystal structure; Figure 1B) that are not described in the crystal
structure in which the C-terminal His207Arg208His209 fragment is undetected (9, 11). This
absence in the crystal was attributed to structural disorder, but possible loss of the Cterminus by an unusual degradation clearly established in solution by 1H NMR and mass
spectrometry(22), has not been yet ruled out. In any case, these contacts have been assigned
to His207 and Arg208, and were confirmed by C-terminal deletion (22). A molecular model
(24) based on limited energy minimization using NOESY constraints and a series of three
salt bridges and one H-bond involving the three C-terminal residues, the side chain of
Lys126, the carboxylate of Asp27 and the propionate at the crystallographic 7-position, is
reproduced in Figure 2. The observation of very similar His207 and Arg208 interactions
with the active site with each of the modified substrates indicates that the architecture of the
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interaction of the C-terminus with the active site is qualitatively retained upon loss of the 7propionate to Arg208 salt bridge.
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The relatively modest effect on the C-terminal structure upon deleting the 7 propionate
could be attributed to the failure of the 7 propionate to interact with the C-terminus, as
described by our model (22, 24). However, the 13C chemical shift for the PHIX propionate
carboxylates (Figure 7) is strongly perturbed for the 7 propionate, but not for the 6
propionate, upon C-terminal cleavage, confirming that the 7 propionate does interact with
the C-terminus in the native complex. The loss of the 7 propionate salt bridge may weaken,
but not significantly rupture, the interaction of the C-terminus with the active site. This
confirms the relatively robust nature of this interaction of the C-terminus with the active site
(24). Qualitative changes upon deleting the 7 propionate include slightly altered hyperfine
shifts for His207 in spite of conserved χ, and more intense NOESY cross peaks between
8CH3 and the His207 CδH than in complexes with the native propionates. Inasmuch as the
C-terminal interaction with the active site in 7-propionate deleted substrates is not
biologically relevant, no attempt was made to model this interaction.
It is not clear whether the propionate at the crystallographic 8-position in NmHO-(7P→M:
8M→P)DMDHIX-N3 interacts with the terminus of Arg208. The molecular model suggests
that the carboxylate of the 8-propionate could orient to form the salt bridge. The fact that the
C-terminal cleavage leads to significant chemical shift changes for the 8-propionate CβH
chemical shifts (−1.50, −0.80 in WT NmHO to −0.80, −0.49 in NmHOX) suggests that a salt
bridge between the 8 propionate and Arg208 side chain may occur in this complex.
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NMR studies (22, 24) with variably 2-,4-disubstituted substrates had shown that the rate of
C-terminal cleavage correlates with the proximity of the His207 to the substrate, with the
rate of cleavage significantly enhanced upon replacing the bulky vinyls with methyls or
hydrogens. Both (6P→M)PHIX and PHXIII have the vinyl at the crystallographic 1 position
oriented trans (Hβs close to position 8; see Figures 3B and 3C), which will sterically
interfere with His207 approaching the substrate. The retarded rates of cleavage for these two
modified substrates are consistent with its model.
Comparison to other HOs and functional implications
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Clearly NmHO requires but a single propionate salt bridge to the protein matrix to
effectively bind substrate, in contrast to mammalian HO (15, 16). Moreover, protohemin-I
(the analog to (7P→M:8M→P)PHIX, but with 2,4-vinyls) fails to yield an active hHO
complex (15). In contrast, the (7P→M:8M→P)PHIX complex (Figure 3F) retains full
activity in NmHO. The fact that deleting one propionate abolishes substrate binding for hHO
but not NmHO dictates that other substrate-enzyme interactions must be stronger in the
NmHO than hHO complex. Since one salt bridge between the propionate at position 6
(Figure 1) with the side chain terminus of a Lys (Lys16 for NmHO, Lys18 for hHO) is
conserved, it is reasonable to attribute the stronger interactions in NmHO to van der Waals
contacts primarily with pyrroles A and B. Stronger van der Waals interactions have been
implied in the much more compact active site in crystals (2, 9, 11). A similar conclusion has
been reached on the basis of the much stronger orientational preference of substrates about
the α-, γ-meso axis (27) when compared to other HOs (20, 28-30). Hence, the stronger
substrate-enzyme van der Waals interactions in NmHO substrate complexes can be viewed
as a mechanism for “liberating” one of the two propionates for a functional role unnecessary
in other HOs, namely the ordering of the C-terminus to interact with the active site.
The solution NMR-detected C-terminal interaction with the active site can be expected to
have functional implications for two distinct processes that most likely occur at the exposed
substrate edge that, in NmHO, is “shielded” by the interaction of the C-terminus with the
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active site (24). On the one hand, HO-biliverdin complexes dissociate too slowly to sustain
effective biological catalysis (25). For mammalian systems the product biliverdin is not
released until a transient 1:1 complex is formed with BVR with contact at the exposed
substrate edge (26). The BVR acts as a cooperative facilitator that significantly accelerates
the rate of biliverdin release and at the same time precludes the presence of significant
concentrations of the toxic biliverdin. While bilirubin may not be toxic for bacteria, there is
still the need for the transient binding of an allosteric effector (the BVR analog) to accelerate
biliverdin release. On the other hand, while cytochrome-P450 reductase and NADPH or
ascorbate react with mammalian systems directly to yield iron-free biliverdin (3), the same
reactions with NmHO complexes proceed only to the iron (III)-biliverdin complex where the
iron can only be extracted by a powerful iron chelator (2, 49). The final reduction step for
NmHO complexes must rely on the specific NmHO electron donor. It is possible, that once
the iron biliverdin complex of NmHO is formed, the native electron donor protein may serve
as both a source of the key electron for the iron as well as an allosteric effector to labilize the
resulting iron-free biliverdin. Unfortunately, neither the BVR analog nor the electron donor
in pathogenic bacteria is known (2). A more detailed understanding of the fate of biliverdin
in N. meningitidis would be necessary to provide fruitful insight into the unique C-terminal
structural role of NmHO.

CONCLUSIONS
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NmHO binds substrates possessing a single propionate to form active complexes by either
deleting or rearranging the position of one of the propionates of the substrate. This is in
strong contrast with hHO where neither the propionate deletion nor rearrangement affords
and active complex. The unique salt bridge for NmHO is between the propionate at the
crystallographic 6 position and the terminus of Lys16. The second substrate propionate at
the normal crystallographic 7 position (and possibly at the unprecedented 8 position), forms
a salt bridge to the (crystallographically undetected) side chain of Arg208 as a portion of the
stabilization of the interactions of the C-terminus with the active site. The solvent-exposed
side of the substrate consisting of the crystallographic 1 and 8 positions interacts with the Cterminus in a qualitative conserved manner upon elimination of the 7-propionate, as
described by an earlier molecular model (24), although altered hyperfine shifts suggest some
minor rearrangement in the C-terminus architecture. Spontaneous C-terminal cleavage
abolishes the characteristic contacts between the C-terminus and active site with the
exception for substrates oriented with the vinyl group at the crystallographic 1 position,
which interferes with the interaction of the C-terminus with the active site. The effective
binding of a substrate with a single propionate by NmHO, instead of the required two from
mammalian HOs, is attributed to a larger contribution to the substrate binding from
peripheral van der Waals interactions, as supported by more compact structure (2, 9, 11),
fewer vacancies and much stronger orientational preference about the α,γ-meso axis (27).
These structural differences are proposed to have evolved, in part, to “liberate” one
propionate for stabilizing interactions of the active site with the C-terminus, which, in turn,
is proposed to function in product release.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.

Abbreviations used
BVR

biliverdin reductase

DSS

2,2-dimethyl-2-silapentane-5-sulfonate
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HO

heme oxygenase

hHO

human heme oxygenase-1

NmHO

Neisseria meningitidis heme oxygenase

CdHO

Corynebacterium diphtheriae heme oxygenase

PaHO

Pseudomonas aeruginosa heme oxygenase

NOESY

two-dimensional nuclear Overhauser spectroscopy

TOCSY

two-dimensional total correlation spectroscopy

ROESY

rotating-frame two-dimensional Overhauser spectroscopy

PHIX

protohemin-IX

PHXIII

protohemin-XIII

DMDHIX

2-,4-dimethyldeuterohemin-IX

(6P→M)PHIX

6-de-propionate-,6-methyl-protohemin-IX

(7P→M)PHIX

7-de-propionate-,7-methyl-protohemin-IX

(7P→M)DMDHIX

7-de-propionate-,7-methyl-2-,4-dimethyldeuterohemin-IX

(7P→M:
8M→P)DMDHIX

7-de-propionate-,7-methyl,8-de-methyl,8-propionate-2-,4dimethyldeuterohemin-IX
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Figure 1.
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Orientation of native protohemin-IX within the active site of: (A) human HO (8), hHO,
showing the key salt bridges of the 6-propionate with the side chain of Lys18 and the 7propionate with the side chain of Arg183; and (B) NmHO (9, 11) showing the conserved salt
bridge between the 6-propionate and Lys16, as well as two residues, Cys113, Phe123, key to
determining the orientation of substrate in the active site. The contacts of two residues not
detected in the crystal structure, His207 with M1 and M8 and Arg208 with M8, are also
shown in bold.
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Figure 2.

Proposed molecular model (24) for the C-terminus of substrate-bound NmHO determined by
limited energy minimization based on the proposed donor-acceptor interactions (arrows)
His207 (green) peptide NH H-bond donor to carboxylate of Asp27 (gray) and the Arg208
(blue) guanidyl group salt bridges to the carboxylates of the 7-propionate (red) and Cterminal His209 carboxylate, which in turn, is an acceptor to the side chains of both Lys126
and Arg208.
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Figure 3.
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Structure and labeling of modified hemins relevant to the present study (M = methyl); the
orientation of the vinyls groups relative to the adjacent methyl on the same pyrrole is shown
as deduced by NOESY cross peaks in solution. (A) 7-de-propionate-,7-methyl-protoheminIX, (7P→M)PHIX; (B) 6-de-propionate-,6-methyl-protohemin-IX, (6P→M)PHIX; (C)
protohemin-XIII, PHXIII; (D) 2-,4-dimethyldeuterohemin-IX, DMDHIX; (E) 7-depropionate-,7-methyl-2-,4-dimethyldeuterohemin-IX, (7P→M)DMDHIX; (F) 7-depropionate-,7-methyl, 8-de-methyl-,8-propionate-2-,4-dimethyldeuterohemin-IX, (7P→M:
8M→P)DMDHIX. The orientations of the substrates, relative to the protein matrix, are
depicted as found in the active site shown in Figure 1B, and the determined vinyl
orientations are shown at cis (vinyl Hβ next to methyl on the same pyrrole) or trans (vinyl
Hα next to methyl on the same pyrrole). The arbitrary labeling of the pyrrole positions in
two-fold symmetric PHXIII and in the DMDHIX derivatives is selected so as to correspond
to the same number position of PHIX in the crystal structure.
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Figure 4.

Resolved portions of the 600 MHz 1H NMR reference spectra, in 1H2O, 50 mM phosphate,
75 mM azide, pH 7.1 at 25°C, for: (A) WT NmHO-PHIX-N3; (B) WT NmHO(7P→M)PHIX-N3; (C) WT NmHO-(6P→M)PHIX-N3; and (D) WT NmHO-PHXIII-N3.
The spectrum for the “aged” or C-terminal cleaved NmHO complex, NmHOX(7P→M)PHIX-N3, is shown in (B’).
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Figure 5.

Resolved portions of the 600 MHz 1H NMR reference spectrum, in 1H2O, 50 mM
phosphate, 75 mM azide, pH 7.1 at 25°C for: (A) WT NmHO-DMDHIX-N3; (B) WT
NmHO-(7P→M)DMDHIX-N3; and (C) WT NmHO-(7P→M:8M→P)DMDHIX-N3. The
NMR spectra of the “degraded” or C-terminal cleaved complexes, NmHOX(7P→M)DMDHIX-N3, and NmHOX-(7P→M:8M→P)DMDHIX-N3, are shown in (B’) and
(C’), respectively.
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Figure 6.
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Resolved portions of the 600 MHz 1H NMR NOESY spectrum, in 1H2O, 50 mM phosphate,
75 mM azide, pH 7.1 at 25°C for WT NmHO-(7P→M)PHIX-N3; illustrating key intrasubstrate (A, B, G, H), substrate residue contacts (A, C, D, E, and I) for Phe52, Cys113,
Phe123, Leu124, His207 and Arg208, and intra-residue contacts (C, F) for His207 that
uniquely assign the substrate and determine the orientation of the substrate in the pocket.
Noted are the His207 CβH and CδH contact with M8 (E, I) and His207 with M1 (E). Panels
(A’, D’, E’ and G’) for the C-terminal cleaved complex NmHOX-(7P→M)PHIX-N3 exhibit
the same data as panels A, B, D, E, G, H for the WT complex; except for the loss of the
His207 and Arg208 cross peaks to M8/M1. All panels except C, F and I utilize 45 ppm
bandwidth, 2.5 s−1 repetition rate and 45° phase-shifted sine-bell apodization; panels C, F
and I utilize 20 ppm bandwidth, 1.0 s−1 repetition rate and 30° phase-shifted sine-bell
apodization.
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Figure 7.

Portion of the 151 MHz 13C NMR reference spectrum for the carboxylate chemical shift
window for: (A) ~90% WT NmHO-(6-,7-13CO −2)2PHIX-H2O, ~10% C-terminal cleaved
NmHOX-(6-,7-13CO −2)2PHIX-H2O; (B) ~70% WT NmHO-(6-,7-13CO −2)2PHIX-H2O,
~30% C-terminal cleaved NmHOX-(6-,7-13CO −2)2PHIX-H2O; and (C) ~75% WT NmHO(6-13CO −2)PHIX-H2O, ~25% C-terminal cleaved NmHOX-(6-13CO −2)PHIX-H2O, which
assign peaks a and b to the 7- and 6-propionate carboxylates, respectively, in the WT NmHO
complex, and peaks c and d to the 6- and 7-carboxylates, respectively, in the C-terminal
cleaved NmHOX complex.
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Orientation rotated 180° about the α,γ-meso axis relative to that in the crystal.

e)

d)

Crystallographic orientation, as in Figure 1B.

c)

Substrate structures and proton labels are shown in Figure 3.

b)

Chemical shifts in ppm, referenced to DSS, in 1H2O, 50 mM phosphate, 75 mM azide, pH ~7.1 and 25°C.
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Chemical shifts for variable substrates in azide complexes of WT NmHOa)
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Vinyl Hα chemical shifts are given in parentheses; vinyl and propionate CβH chemical shifts are provided in Supporting Information, Tables S1 and S2.
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